Supreme Court's Decision on OxyContin Maker's Bankruptcy Deal Holds Billions at Stake

The Supreme Court is hearing arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield the Sackler family, who own the company, from civil lawsuits related to the toll of opioids. The agreement, which would provide billions of dollars to combat the opioid epidemic, has been put on hold due to objections from the Biden administration. The issue at hand is whether bankruptcy protection can be extended to individuals like the Sacklers who have not declared bankruptcy themselves. Lower courts have issued conflicting decisions on this matter, which has implications for other major product liability lawsuits settled through bankruptcy. The decision is expected by early summer.
- OxyContin maker bankruptcy deal goes before the Supreme Court on Monday, with billions at stake The Associated Press
- At Core of Purdue Pharma Case: Who Can Get Immunity in Settlements? The New York Times
- The Opioid Victims Who Won't Sign Off on Purdue's $6 Billion Settlement The Wall Street Journal
- How will the Supreme Court reshape US opioid epidemic relief? Yahoo Finance
- Fate of Billions for Opioid Victims From Sacklers Rests With Supreme Court The New York Times
Reading Insights
0
0
2 min
vs 3 min read
81%
560 → 109 words
Want the full story? Read the original article
Read on The Associated Press